Efficacy News and Research

RSS

New copper surface could help fight antibiotic-resistant superbugs

A new copper surface that kills bacteria more than 100 times faster and more effectively than standard copper could help combat the growing threat of antibiotic-resistant superbugs.

13 Dec 2021

SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

13 Dec 2021

Researchers develop a universal SARS-CoV-2 neutralizing antibody

A new study has been published in Frontiers in Immunology, where scientists developed a universal SARS-CoV-2 neutralizing antibody, MG1141A.

13 Dec 2021

Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations

Study reveals that the most beneficial vaccination strategy is to distribute all available doses of COVID-19 vaccines predominantly for primary vaccinations and the remaining doses for boosters.

12 Dec 2021

Efficacy of BNT162b2 vaccine booster in reducing mortality due to COVID-19

A recent observational study in Israel evaluates the efficacy of a Pfizer vaccine booster dose in reducing the mortality rate of COVID-19.

12 Dec 2021

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

Researchers determined antibody-mediated neutralization efficacy against the authentic SARS-CoV-2 Omicron variant.

12 Dec 2021

UK Prime Minister and the NHS launch urgent appeal calling for people to get Covid jabs

The Prime Minister, together with the NHS, has today [Sunday 12 December] launched an urgent national appeal calling for people to get jabbed, as he outlined plans to significantly increase NHS vaccination capacity.

12 Dec 2021

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Published today, one of the earliest, peer-reviewed studies looking into the Omicron variant of COVID-19 suggests that people previously infected with COVID, and those vaccinated, will have some, "stronger than basic" defense against this new strain of concern.

12 Dec 2021

Novel therapy found to be safe and well-tolerated in patients with bone marrow cancer

Mount Sinai physician-scientists have found that a novel therapy for the bone marrow cancer myelofibrosis is safe and well-tolerated and is associated with modest improvements in patients in a Phase 1b clinical trial.

12 Dec 2021

Study finds mutational changes in Omicron variant likely increase transmissibility

A new study presented evidence for a large number of mutational changes in the Omicron variant which will likely increase its transmissibility and significantly decrease the neutralization capacity of monoclonal antibodies, leading to a decline in vaccine efficacy.

10 Dec 2021

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Researchers have screened several compounds that could show the ability to inhibit SARS-CoV-2.

10 Dec 2021

Subcutaneous defibrillators equally effective in delivering electric shocks, study says

Electric shocks delivered by subcutaneous defibrillators are equally effective compared to shocks delivered by conventional transvenous defibrillators, according to a study published in the journal Circulation.

9 Dec 2021

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

9 Dec 2021

Prescribing generic heart medications in Medicare Part D could result in substantial savings

Prescribing generic medications for heart and blood vessel diseases more frequently instead of brand-name medications in Medicare's prescription drug program, called Part D, could save more than $600 million each year in the U.S., according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

9 Dec 2021

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11.

9 Dec 2021

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants.

9 Dec 2021

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Researchers from Sorbonne Universite have been investigating the effect of the BNT162b2 mRNA vaccine on HIV-positive individuals.

9 Dec 2021

Immunogenicity and safety of COVID-19 subunit vaccine Nanocovax in animal models

Researchers have developed Nanocovax, a COVID-19 subunit vaccine based on recombinant protein technology to produce the extracellular (soluble) portion of the S protein of SARS-CoV-2.

9 Dec 2021

Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling

A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components.

From Yokogawa Life Science 9 Dec 2021

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects, adults 18 years and above, across six countries.

9 Dec 2021

Efficacy News and Research

New copper surface could help fight antibiotic-resistant superbugs

SARS-CoV-2 omicron variant may evade host immune responses

Researchers develop a universal SARS-CoV-2 neutralizing antibody

Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations

Efficacy of BNT162b2 vaccine booster in reducing mortality due to COVID-19

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

UK Prime Minister and the NHS launch urgent appeal calling for people to get Covid jabs

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Novel therapy found to be safe and well-tolerated in patients with bone marrow cancer

Study finds mutational changes in Omicron variant likely increase transmissibility

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Subcutaneous defibrillators equally effective in delivering electric shocks, study says

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

Prescribing generic heart medications in Medicare Part D could result in substantial savings

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Immunogenicity and safety of COVID-19 subunit vaccine Nanocovax in animal models

Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News